Archives

Bloomberg has authored an investigative piece exposing drug cost middlemen, better known as pharmacy benefit managers (PBMs), for their role

Gilead Sciences is turning to gene editing in its effort to develop a cure for hepatitis B virus infections-DNA-cutting enzymes

Nebraska City’s City Council, Mayor Bryan Bequette and other officials will participate in the city’s first-ever Twitter town hall meeting

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: ERC-2018-PoCPillar: Excellent ScienceOpening Date: Deadline: Tue, 11 Sep 2018 17:00:00 (Brussels local time)Modification Date: Wed, 12 Sep

Andrew Cheng has been appointed president and CEO of Cambridge, MA-based Akero Therapeutics. Cheng comes to Akero following a nearly

[Source: Research & Innovation] The transition toward clean, efficient and secure energy will require more than just technological innovation. An

The numbers are staggering. The opioid epidemic is costing our nation more than $500 billion annually in health and social costs. What’s

Houston-OncoResponse, a Seattle biotech startup formed jointly with the University of Texas M.D. Anderson Cancer Center in Houston, announced Tuesday

[Source: Research & Innovation] The emerging bioeconomy is moving from research niche to market norm and Europe needs to maintain

Congress, the Food and Drug Administration (FDA), drug developers, researchers and patient groups have all recognized the contribution patients and